Dual enzyme biocatalyst

19-Mar-2009 - United Kingdom

A range of enantiomerically pure chiral amines have been prepared by a collaboration of scientists in the UK and the US.

Nicholas Turner and Matthew Truppo from the University of Manchester and a co-worker from Codexis Incorporated, California, have synthesised a range of enantiomerically pure (R)- and (S)-configured chiral amines.

Enantiomerically pure chiral amines are important as they have applications in a number of different areas including building blocks for pharmaceuticals, resolving agents and ligands for asymmetric synthesis. In order to minimize the cost of production it is important to devise efficient catalytic methods for their preparation, particularly on a large scale.

Turner and his team have developed a novel biocatalytic system, involving the use of two enzymes (transaminase and amino acid oxidase), for the kinetic resolution of a range of racemic amines. Both (R)- and (S)-configured chiral amines can be prepared using this approach with high enantioselectivity (e.e. >99%). Turner explains that ‘the key to our method is to use a catalytic (as low as 0.05 mol%) quantity of the amine acceptor pyruvate, which is converted to alanine during the transamination of a ketone substrate. The addition of L- or D-amino acid oxidase results in the efficient conversion of the alanine back to pyruvate.’

‘The process is fast, generally applicable, and should be amenable to rapid scale-up by those in industry wishing to apply this method to specific chiral amines of interest,’ says Turner.

Original article: Matthew D. Truppo et. al.; "Efficient kinetic resolution of racemic amines using a transaminase in combination with an amino acid oxidase"; Chem. Commun. 2009

Other news from the department science

Most read news

More news from our other portals

Last viewed contents

Analytik Jena Wins Major Order in Poland

Schizophrenia manifests itself in the brain structure - The symptoms of schizophrenia vary greatly from person to person

Schizophrenia manifests itself in the brain structure - The symptoms of schizophrenia vary greatly from person to person

The race is on for new lithium ion batteries - Battery consortium headed by BASF receives € 21 million sponsorship from German Ministry of Education and Research

Antibiotic resistance testing no longer impeded by time - Researchers have developed a novel method for antibiotic resistance testing that might transform microbial screening in clinical and research labs

Antibiotic resistance testing no longer impeded by time - Researchers have developed a novel method for antibiotic resistance testing that might transform microbial screening in clinical and research labs

A new way to stimulate cellular recycling process

A new way to stimulate cellular recycling process

Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement - Offer price increased

Thermo Fisher Scientific and QIAGEN N.V. Agree on Amended Terms to Acquisition Agreement - Offer price increased

New insights into the function of a risk factor for Alzheimer’s disease - Researchers decipher the structure-function relationship of the multifunctional protein clusterin for the first time

New insights into the function of a risk factor for Alzheimer’s disease - Researchers decipher the structure-function relationship of the multifunctional protein clusterin for the first time

Rigaku opens Rigaku Technology Center Taiwan - Advancing regional growth through engineering and collaboration in Taiwan and beyond

Rigaku opens Rigaku Technology Center Taiwan - Advancing regional growth through engineering and collaboration in Taiwan and beyond

Multiplexed Morse signals from cells

Multiplexed Morse signals from cells

Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA and Coeliac disease

Closing in on the elusive rotational-vibrational CH5+ spectra

New model predicts a chemical reaction’s point of no return - Chemists could use this quick computational method to design more efficient reactions that yield useful compounds, from fuels to pharmaceuticals

New model predicts a chemical reaction’s point of no return - Chemists could use this quick computational method to design more efficient reactions that yield useful compounds, from fuels to pharmaceuticals